11.17.22 -- Inside Autonomous Supply Chain Planning

By unlocking the value of an integrated solutions provider, you can leverage a comprehensive suite of advanced technologies and expertise that will facilitate your path to market and benefit you for the lifetime of your product.

Don’t settle for recycled employees poached from other studies when therapeutically-aligned, passionate, and accountable personnel — eager to work on your specific study — are available.

Learn about implementing automated technologies like robotics to overcome growing issues with sterility assurance and data integrity.

Identify and examine the key trends in the advanced therapy medicinal product (ATMP) industry and explore their impact on companies across a range of concerns, including speed to market, efficiency, safety, and innovation.

Thorough consideration of cleaning/disinfection during facility design eases maintenance across the facility life cycle, optimizes workspace utility, and contributes to efficient facility operation.

Qualified reference standards play a critical role in providing validated benchmarks to satisfy regulatory requirements pertaining to purity.

Discover our DMSO-free chemically defined cryopreservation medium that has shown statistically significant improvements in post-thaw viable cell recovery and cell functionality when compared to DMSO-containing solutions.

In this webinar, learn how light scattering techniques have become powerful tools for characterizing various attributes, including molar mass, size, aggregation, physical titer, thermal, and colloidal stability.

Gene therapies are transformative medicines that hold promise for treating diverse, genetically-driven diseases. Explore the essential components of a gene therapy.

Due to its therapeutic impact on a wide range of diseases and disorders, adeno-associated virus (AAV) gene therapy is one of the most promising advances in modern medicine.

In a recent live event with Bioprocess Online, industry experts at various stages of their automation journey discussed their approach to enhancing quality control and data integrity through automated technologies.

We review a procedure to adapt suspension CHO and 293 cultures, which also serves as a general protocol that has been successful with multiple other cell types and media.

We demonstrate a system that combines all of the qPCR features scientists want in a single high-performance instrument so that you can optimize your research productivity.

Over the last five years, the use of 24-well cell culture plates in laboratory applications has substantially increased. This market segment has expanded at an estimated 14% compound annual growth rate (CAGR) — a pace that is expected to continue in coming years. This paper explores the evaluation of the potential applications for its new AcroPrep 24-well filter plate line, plus the time savings it can achieve in protein purification workflows.

Read how modular and vendor-agnostic end-to-end process solutions helped save CAPEX, while increasing process speed at different scales help reduce OPEX for a CDMO.

Breakthrough manufacturing automation for cell expansion, formulation, and working cell bank dispensing paves the way for the treatment of debilitating illness.

To deliver multi-leg shipments of crucial stem cell samples on-time and within specifications, samples had to be collected from Japanese apheresis treatment centers and transported to a U.S. manufacturing plant within 24 hours.

Even though everyone applauds the renewed focus on patients as a positive development, some say it is time for biopharma companies to turn their attention to another audience: clinical trial participants.

With the significant financial costs and clinical risks involved in bringing a new injectable drug product to market, why isn’t reformulation or repurposing being used more often to meet these challenges? This interview with Dr. Tom Tice, one of the world’s leading experts on extended release injectables and implants, reviews current and emerging areas of reformulation focus and some best practices to get your strategy right.

This panel discussion highlights technical and regulatory hurdles associated with development and manufacturing steps and strategies and solutions to facilitate development through commercialization.